These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17003837)

  • 21. C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension.
    Cottone S; Mulè G; Nardi E; Vadalà A; Lorito MC; Guarneri M; Arsena R; Palermo A; Cerasola G
    J Hypertens; 2007 Feb; 25(2):423-8. PubMed ID: 17211250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease.
    Sartori-Valinotti JC; Iliescu R; Fortepiani LA; Yanes LL; Reckelhoff JF
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):938-45. PubMed ID: 17645644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.
    Savoia C; Schiffrin EL
    Clin Sci (Lond); 2007 Jun; 112(7):375-84. PubMed ID: 17324119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension: a microvascular and tubulointerstitial disease.
    Johnson RJ; Rodríguez-Iturbe B; Schreiner GF; Herrera-Acosta J
    J Hypertens Suppl; 2002 Jun; 20(3):S1-7. PubMed ID: 12184051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of immunocompetent cell renal infiltration in the pathogenesis of arterial hypertension].
    Rodríguez-Iturbe B
    Nefrologia; 2008; 28(5):483-92. PubMed ID: 18816206
    [No Abstract]   [Full Text] [Related]  

  • 26. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
    Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
    Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension.
    Vaziri ND
    Curr Opin Nephrol Hypertens; 2004 Jan; 13(1):93-9. PubMed ID: 15090865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvascular oxidative stress, immune reaction and apoptosis in hypertensives.
    Suzuki H; Suematsu M; Schmid-Schönbein GW
    Clin Hemorheol Microcirc; 1999; 21(3-4):161-8. PubMed ID: 10711738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats.
    Koga Y; Hirooka Y; Araki S; Nozoe M; Kishi T; Sunagawa K
    Hypertens Res; 2008 Nov; 31(11):2075-83. PubMed ID: 19098380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal infiltration of immunocompetent cells: cause and effect of sodium-sensitive hypertension.
    Rodriguez-Iturbe B
    Clin Exp Nephrol; 2010 Apr; 14(2):105-11. PubMed ID: 20169462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension: Focus on autoimmunity and oxidative stress.
    Small HY; Migliarino S; Czesnikiewicz-Guzik M; Guzik TJ
    Free Radic Biol Med; 2018 Sep; 125():104-115. PubMed ID: 29857140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.
    Crowley SD
    Antioxid Redox Signal; 2014 Jan; 20(1):102-20. PubMed ID: 23472597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-18, a potential mediator of inflammation, oxidative stress, and allograft dysfunction.
    Khanna A
    Transplantation; 2011 Mar; 91(5):590-1. PubMed ID: 21336087
    [No Abstract]   [Full Text] [Related]  

  • 36. The answer: angiotensin II. The question: what do inflammation, oxidant stress and fibrogenesis have in common?
    Friedman SL
    J Hepatol; 2004 Jun; 40(6):1050-2. PubMed ID: 15158358
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oxidative stress and hypertension].
    Violi F
    Ann Ital Med Int; 2001; 16(2):67-8. PubMed ID: 11688362
    [No Abstract]   [Full Text] [Related]  

  • 38. Oxidative stress and central cardiovascular regulation. - Pathogenesis of hypertension and therapeutic aspects -.
    Hirooka Y; Sagara Y; Kishi T; Sunagawa K
    Circ J; 2010 May; 74(5):827-35. PubMed ID: 20424336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension as an autoimmune and inflammatory disease.
    Solak Y; Afsar B; Vaziri ND; Aslan G; Yalcin CE; Covic A; Kanbay M
    Hypertens Res; 2016 Aug; 39(8):567-73. PubMed ID: 27053010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications.
    Ndisang JF; Vannacci A; Rastogi S
    Oxid Med Cell Longev; 2014; 2014():506948. PubMed ID: 24723993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.